Advertisement
Advertisement
Utah Medical Products, Inc. (UTMD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Follow
At close: 04:00PM EDT
After hours:
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 83.86 |
| Open | 84.33 |
| Bid | 81.45 x 800 |
| Ask | 88.22 x 800 |
| Day's Range | 83.89 - 85.04 |
| 52 Week Range | 80.68 - 109.50 |
| Volume | |
| Avg. Volume | 12,664 |
| Market Cap | 305.896M |
| Beta (5Y Monthly) | 0.24 |
| PE Ratio (TTM) | 17.78 |
| EPS (TTM) | 4.74 |
| Earnings Date | Oct 23, 2023 - Oct 27, 2023 |
| Forward Dividend & Yield | 1.18 (1.41%) |
| Ex-Dividend Date | Sep 14, 2023 |
| 1y Target Est | N/A |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
-3% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for UTMD
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- Utah Medical Products, Inc.Analyst Report: West Pharmaceutical Services, Inc.West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.RatingFair ValueEconomic Moat3 days agoMorningstar
Simply Wall St.Utah Medical Products, Inc. (NASDAQ:UTMD) Looks Interesting, And It's About To Pay A Dividend
Utah Medical Products, Inc. ( NASDAQ:UTMD ) is about to trade ex-dividend in the next four days. Typically, the...
ACCESSWIREUTMD Updates Status of Filshie Product Liability Lawsuits in the U.S.
As Utah Medical Products, Inc.'s (NASDAQ:UTMD's) stockholders know, the following disclosure was included in the Company's 2022 SEC 10-K annual report, released in March 2023:
- Simply Wall St.
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.295
The board of Utah Medical Products, Inc. ( NASDAQ:UTMD ) has announced that it will pay a dividend of $0.295 per share...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
